Additive value of platelet rich plasma (PRP) in surgical treatment of stable vitiligo .A randomized double blind comparative study.
- Disease/Condition
- Skin and Connective Tissue Diseases
- Intervention type
- procedure
- Primary sponsor
- Dr. Dalia Abdel Halim
- Location
- Egypt
- Phase
- Phase 4
- Start date
- Jan 01, 1900
- End date
- Jan 01, 1900
Vitiligo is a quite distressing and challenging skin disorder. Vitiligo surgery; with non cultured epidermal cell suspension (NCES) being one of the most commonly used techniques, provides hope for otherwise resistant cases. However, in spite of improving the overall success rate of vitiligo treatment, it fails to achieve successful repigmentation in a good number of cases.Platelet rich plasma (PRP)has high growth promoting ,healing and regenerative capacity being rich in a multitude of growth factors like platelet derived growth factor (PDGF), transforming growth factor beta (TGF b), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and insulin‐like growth factor (IGF).We assume that these growth factors, especially bFGF in PRP, would stimulate melanocyte migration along with the stimulation of keratinocytes and fibroblast proliferation. The addition of PRP to NCES thus should increase the rate and extent of repigmentation. Our objective is to assess the value of adding of PRP to the NCES via detecting percent reduction in the extent of vitiligo lesions treated by PRP suspended NCES compared to ones treated by saline suspended NCES through point counting technique as well as comparing improvement in pigmentation using VESTA Score (vitiligo extent score for a target area).
- Registry
- Pan Africa Clinical Trials Registry
- Trial ID
- PACTR202108873035929
- Type
- Non-Device Trial
Access comprehensive clinical trial information for PACTR202108873035929 through Pure Global AI's free database. This Phase 4 trial is sponsored by Dr. Dalia Abdel Halim and is currently Completed. The study focuses on Skin and Connective Tissue Diseases.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.